Sciencast Management LP Trims Holdings in The Campbell’s Company $CPB

Sciencast Management LP trimmed its holdings in shares of The Campbell’s Company (NASDAQ:CPB) by 30.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 93,953 shares of the company’s stock after selling 41,023 shares during the quarter. Sciencast Management LP’s holdings in Campbell’s were worth $2,092,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in CPB. Flagship Harbor Advisors LLC bought a new position in shares of Campbell’s in the fourth quarter worth about $29,000. Sittner & Nelson LLC bought a new stake in Campbell’s during the 4th quarter valued at about $29,000. Los Angeles Capital Management LLC bought a new stake in Campbell’s during the 4th quarter valued at about $29,000. Ankerstar Wealth LLC purchased a new stake in Campbell’s in the 4th quarter valued at about $29,000. Finally, IMA Advisory Services Inc. purchased a new stake in Campbell’s in the 4th quarter valued at about $33,000. 52.35% of the stock is owned by hedge funds and other institutional investors.

Campbell’s Price Performance

NASDAQ CPB opened at $23.28 on Friday. The company has a market cap of $6.94 billion, a PE ratio of 11.52 and a beta of 0.02. The firm’s 50 day moving average price is $22.28 and its 200-day moving average price is $22.86. The company has a debt-to-equity ratio of 1.53, a quick ratio of 0.38 and a current ratio of 0.87. The Campbell’s Company has a 52-week low of $19.56 and a 52-week high of $34.17.

Campbell’s (NASDAQ:CPB) last issued its quarterly earnings data on Monday, June 8th. The company reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. The company had revenue of $2.37 billion during the quarter. Campbell’s had a net margin of 6.12% and a return on equity of 18.04%. The business’s quarterly revenue was down 4.4% on a year-over-year basis. During the same period last year, the firm earned $0.22 EPS. Campbell’s has set its FY 2026 guidance at 2.150-2.250 EPS. Sell-side analysts forecast that The Campbell’s Company will post 2.18 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

CPB has been the topic of a number of research reports. Morgan Stanley reduced their target price on shares of Campbell’s from $23.00 to $21.00 and set an “equal weight” rating on the stock in a research report on Friday, June 5th. BTIG Research reiterated a “neutral” rating on shares of Campbell’s in a report on Monday, June 8th. Stifel Nicolaus boosted their price target on Campbell’s from $20.00 to $22.00 and gave the company a “hold” rating in a report on Wednesday, July 22nd. William Blair initiated coverage on Campbell’s in a research note on Tuesday, June 23rd. They issued a “market perform” rating on the stock. Finally, Zacks Research upgraded Campbell’s from a “strong sell” rating to a “hold” rating in a report on Monday. Twelve investment analysts have rated the stock with a Hold rating and seven have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Reduce” and an average target price of $21.20.

About Campbell’s

Campbell’s (NASDAQ: CPB) is a leading manufacturer of shelf-stable foods and beverages, best known for its iconic soups and broths. Headquartered in Camden, New Jersey, the company offers a diverse portfolio of products designed to meet consumer demand for convenient, affordable meals and snacks. Since its founding in 1869, Campbell’s has grown through a combination of organic innovation and strategic acquisitions to expand its presence in the food industry.

The company’s brand portfolio includes Campbell’s Condensed Soups, V8 juices, Prego pasta sauces, Swanson broths and stocks, Pace salsas and dips, and Pepperidge Farm baked snacks.